Last reviewed · How we verify

SLIT Grazax ALK Nordic 75 000 SQ-T — Competitive Intelligence Brief

SLIT Grazax ALK Nordic 75 000 SQ-T (SLIT Grazax ALK Nordic 75 000 SQ-T) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

phase 2 Small molecule Live · refreshed every 30 min

Target snapshot

SLIT Grazax ALK Nordic 75 000 SQ-T (SLIT Grazax ALK Nordic 75 000 SQ-T) — Lars Olaf Cardell.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
SLIT Grazax ALK Nordic 75 000 SQ-T TARGET SLIT Grazax ALK Nordic 75 000 SQ-T Lars Olaf Cardell phase 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SLIT Grazax ALK Nordic 75 000 SQ-T — Competitive Intelligence Brief. https://druglandscape.com/ci/slit-grazax-alk-nordic-75-000-sq-t. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: